CLOs on the Move

Tarsus Pharmaceuticals

www.tarsusrx.com

 
Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tarsusrx.com
  • 15440 Laguna Canyon Road Suite 160
    Irvine, CA USA 92618
  • Phone: 949.409.9820

Executives

Name Title Contact Details
Bryan Wahl
 General Counsel Profile

Similar Companies

Saranas

Early Bird is the first and only FDA-approved bleed detection system for peri and post-procedural monitoring of endovascular procedures.

Little Leaves Behavioral Services

Ionetix

Ionetix Corporation is a pioneering radiopharmaceutical end to end solutions provider for cardiac PET. Cardiac PET with Ammonia N-13.

Supply Chain Logistics

Supply Chain Logistics is a Utica, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Novopharm

Novopharm is a Scarborough, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.